acquired
Stage
About
Locemia develops a needle-free intranasal glucagon powder to simplify rescue treatment for severe hypoglycemia in diabetes patients.
Explore Locemia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.